Nikièma, Achille Sindimbasba
Koala, Lassane
Bamogo, Rabila
Sawadogo, Simon P.
Badiel, Arielle Bettina Sandra
Ouari, Ali
Millogo, Abdoul-Aziz
Bougouma, Clarisse
Sermé, Mamadou
Traoré, Soungalo
Faye, Babacar
Dabiré, Roch Kounbobr
Funding for this research was provided by:
COR-NTD (SGPV/0102/369)
Article History
Received: 25 July 2025
Accepted: 29 August 2025
First Online: 25 September 2025
Declarations
:
: The study was approved by the ethics committee of Institut de Recherche en Sciences de la Santé (IRSS) under the number A027-2022/CEIRES. The study was conducted in collaboration with the health districts of Dafra and Karangasso Vigué and the National Programme for Control of Neglected Tropical Diseases. For community entry, a team composed of Institut de Recherche en Sciences de la Santé members, the chief of Health and Social Promotion Centre and the community-drug distributor of each village carried out a meeting in each village with communities’ leaders to explain the aim of the study and requested their approval and support for the activities. A second meeting was conducted in each village between the investigation team and the heads of the selected household and collectors to explain the aim of the study and obtain their written informed consent. Collectors and heads of household were free to withdraw from the study at any time. The protocol of this study was submitted to ethics committee for approval.
: Not applicable.
: The authors declare no competing interests.